Novo Nordisk: Exceptional Performance But Overvalued
Sundry Photography/iStock Editorial via Getty Images
Investment thesis
Novo Nordisk (NVO) reported excellent numbers that confirm several long-term growth drivers. Modern societies suffer from what I’d call diseases of affluence such as diabetes and obesity….
